Hurdles to Cardioprotection in the Critically Ill

Area of Science:

• Cardiology
• Cardiovascular Surgery
• Biomedical Engineering

Background:

• Cardiovascular disease is a leading cause of global mortality, with heart failure (HF) posing a growing challenge.
• Heart transplantation (HTx) is the definitive treatment for end-stage HF, but donor organ scarcity limits its application.
• Mechanical circulatory support (MCS) offers an alternative for refractory cardiac disease, yet both MCS and HTx are associated with significant morbidity and mortality.

Purpose of the Study:

• To review the current clinical status of MCS and HTx.
• To summarize the cardiac complications associated with these interventions.
• To highlight ongoing research and strategies for improving patient outcomes.

Main Methods:

• Literature review of current clinical practices in MCS and HTx.
• Analysis of inherent cardiac complications following MCS and HTx.
• Synthesis of current research trends in cardioprotective strategies.

Main Results:

• MCS and HTx are essential for critically ill cardiac patients but are linked to substantial adverse effects, including oxidative damage and arrhythmias with MCS.
• Donor heart scarcity restricts HTx availability, and post-transplant complications remain a concern.
• Despite their life-saving role, both treatments necessitate improved cardioprotective measures.

Conclusions:

• There is a critical need for cardioprotective strategies to mitigate the high morbidity and mortality associated with MCS and HTx.
• Further research into improving cardiac outcomes following these interventions is essential.
• Optimizing these life-saving treatments requires addressing their inherent complications and exploring novel therapeutic approaches.